DK88283A - Fremgangsmaade til fremstilling af triazolderivater - Google Patents

Fremgangsmaade til fremstilling af triazolderivater Download PDF

Info

Publication number
DK88283A
DK88283A DK88283A DK88283A DK88283A DK 88283 A DK88283 A DK 88283A DK 88283 A DK88283 A DK 88283A DK 88283 A DK88283 A DK 88283A DK 88283 A DK88283 A DK 88283A
Authority
DK
Denmark
Prior art keywords
procedure
preparation
triazold
derivatives
triazold derivatives
Prior art date
Application number
DK88283A
Other languages
English (en)
Other versions
DK88283D0 (da
Inventor
John Watson Clitherow
Barry John Price
Roger Hayes
David Edmund Bays
Original Assignee
Glaxo Group Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Glaxo Group Ltd filed Critical Glaxo Group Ltd
Publication of DK88283D0 publication Critical patent/DK88283D0/da
Publication of DK88283A publication Critical patent/DK88283A/da

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D209/00Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom
    • C07D209/02Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom condensed with one carbocyclic ring
    • C07D209/44Iso-indoles; Hydrogenated iso-indoles
    • C07D209/48Iso-indoles; Hydrogenated iso-indoles with oxygen atoms in positions 1 and 3, e.g. phthalimide
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/04Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D249/00Heterocyclic compounds containing five-membered rings having three nitrogen atoms as the only ring hetero atoms
    • C07D249/02Heterocyclic compounds containing five-membered rings having three nitrogen atoms as the only ring hetero atoms not condensed with other rings
    • C07D249/081,2,4-Triazoles; Hydrogenated 1,2,4-triazoles
    • C07D249/101,2,4-Triazoles; Hydrogenated 1,2,4-triazoles with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D249/14Nitrogen atoms
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D295/00Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms
    • C07D295/04Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms
    • C07D295/08Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms substituted by singly bound oxygen or sulfur atoms
    • C07D295/096Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms substituted by singly bound oxygen or sulfur atoms with the ring nitrogen atoms and the oxygen or sulfur atoms separated by carbocyclic rings or by carbon chains interrupted by carbocyclic rings
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D401/00Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/02Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
    • C07D401/04Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings directly linked by a ring-member-to-ring-member bond
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D405/00Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
    • C07D405/02Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings
    • C07D405/12Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings linked by a chain containing hetero atoms as chain links
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D409/00Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms
    • C07D409/02Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings
    • C07D409/12Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings linked by a chain containing hetero atoms as chain links
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D417/00Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00
    • C07D417/02Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings
    • C07D417/12Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings linked by a chain containing hetero atoms as chain links

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Engineering & Computer Science (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
DK88283A 1982-02-24 1983-02-24 Fremgangsmaade til fremstilling af triazolderivater DK88283A (da)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
GB8205431 1982-02-24
GB8205723 1982-02-26

Publications (2)

Publication Number Publication Date
DK88283D0 DK88283D0 (da) 1983-02-24
DK88283A true DK88283A (da) 1983-08-25

Family

ID=26282061

Family Applications (1)

Application Number Title Priority Date Filing Date
DK88283A DK88283A (da) 1982-02-24 1983-02-24 Fremgangsmaade til fremstilling af triazolderivater

Country Status (18)

Country Link
JP (1) JPS58157772A (da)
AU (1) AU1180383A (da)
BE (1) BE896012A (da)
DE (1) DE3306503A1 (da)
DK (1) DK88283A (da)
ES (2) ES8407030A1 (da)
FI (1) FI830609L (da)
FR (1) FR2521993B1 (da)
GB (1) GB2116178B (da)
GR (1) GR77048B (da)
IL (1) IL67990A0 (da)
IT (1) IT1167622B (da)
LU (1) LU84659A1 (da)
NL (1) NL8300697A (da)
NO (1) NO830643L (da)
NZ (1) NZ203384A (da)
PT (1) PT76280A (da)
SE (1) SE8301039L (da)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE3336410A1 (de) * 1983-10-06 1985-04-18 Ludwig Heumann & Co GmbH, 8500 Nürnberg Sulfenamidderivate, verfahren zu ihrer herstellung und diese verbindungen enthaltende arzneimittel
FR2815346B1 (fr) * 2000-10-13 2004-02-20 Servier Lab Nouveaux composes aminotriazolones, leur procede de preparation et les compositions pharmaceutiques qui les contiennent

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE3067920D1 (en) * 1979-03-02 1984-06-28 Glaxo Group Ltd 1,2,4-triazole derivatives, processes for their production and pharmaceutical compositions containing them
GB2063874B (en) * 1979-10-22 1983-09-28 Glaxo Group Ltd Triazole derivatives processes for the preparation thereof and pharmaceutical compositions containing them
EP0029303B1 (en) * 1979-10-22 1985-01-30 Glaxo Group Limited 1,2,4-triazole derivatives, processes for their production and pharmaceutical compositions containing them
EP0029306B1 (en) * 1979-10-23 1984-07-25 Glaxo Group Limited Aminoalkyl compounds, their production and pharmaceutical compositions containing them
FR2477150A1 (fr) * 1980-02-28 1981-09-04 Glaxo Group Ltd Nouveaux derives heterocycliques, procedes pour leur preparation et compositions pharmaceutiques les comportant

Also Published As

Publication number Publication date
IT8347786A0 (it) 1983-02-24
GB2116178B (en) 1985-10-02
IT1167622B (it) 1987-05-13
FR2521993A1 (fr) 1983-08-26
ES526532A0 (es) 1985-11-16
NL8300697A (nl) 1983-09-16
JPS58157772A (ja) 1983-09-19
AU1180383A (en) 1983-09-01
BE896012A (fr) 1983-08-24
FR2521993B1 (fr) 1988-09-16
PT76280A (en) 1983-03-01
NO830643L (no) 1983-08-25
LU84659A1 (fr) 1984-11-08
GB8305147D0 (en) 1983-03-30
GR77048B (da) 1984-09-04
NZ203384A (en) 1985-08-16
ES8602702A1 (es) 1985-11-16
DK88283D0 (da) 1983-02-24
SE8301039D0 (sv) 1983-02-24
DE3306503A1 (de) 1983-09-01
GB2116178A (en) 1983-09-21
FI830609L (fi) 1983-08-25
ES520031A0 (es) 1984-04-01
ES8407030A1 (es) 1984-04-01
SE8301039L (sv) 1983-08-25
FI830609A0 (fi) 1983-02-24
IL67990A0 (en) 1983-06-15

Similar Documents

Publication Publication Date Title
DK301383D0 (da) Fremgangsmade til fremstilling af imidazolderivater
DK1183A (da) Fremgangsmaade til fremstilling af tiazolidinderivater
DK95483A (da) Fremgangsmaade til fremstilling af tetrahydropyranderivater
DK241883A (da) Fremgangsmaade til fremstilling af 1-sulfo-2-oxoazetidinderivater
DK372283A (da) Fremgangsmaade til fremstilling af desoxyuridinderivater
DK63683D0 (da) Fremgangsmade til fremstilling af cephemderivater
DK323083A (da) Fremgangsmaade til fremstilling af 19-thio-androstanderivater
DK309783D0 (da) Fremgangsmade til fremstilling af organoglykosider
DK427083D0 (da) Fremgangsmade til fremstilling af cephemderivater
DK435483D0 (da) Fremgangsmade til fremstilling af fenylcyklobutylderivater
DK261883D0 (da) Fremgangsmade til fremstilling af prostaglandin-d-derivater
DK119083D0 (da) Fremgangsmade til fremstilling af alkanoylpyridinoner
DK162230C (da) Fremgangsmaade til fremstilling af 2-thiacephemderivater
DK317283A (da) Fremgangsmaade til fremstilling af thiadiazolderivater
DK426683A (da) Fremgangsmaade til fremstilling af oxacephalosporinderivater
DK340483D0 (da) Fremgangsmade til fremstilling af fluoralkylerede carbapenemderivater
DK482983A (da) Fremgangsmaade til fremstilling af phenylderivater
DK165583D0 (da) Fremgangsmade til fremstilling af furanderivater
DK424083A (da) Fremgangsmaade til fremstilling af anthracyclinglycosider
DK296383D0 (da) Fremgangsmade til fremstilling af fenaetylaminer
DK542383D0 (da) Fremgangsmade til fremstilling af acridanonderivater
DK219483A (da) Fremgangsmaade til fremstilling af anthracyclinglycosider
DK62283D0 (da) Fremgangsmade til fremstilling af peptidergotalkaloider
DK164283D0 (da) Fremgangsmade til fremstilling af benzimidazolderivater
DK9383A (da) Fremgangsmaade til fremstilling af phosphinoxider

Legal Events

Date Code Title Description
AHB Application shelved due to non-payment